Radicle Energy: A Study of Cannabinoids on Energy and Other Health Outcomes

November 20, 2023 updated by: Radicle Science

Radicle™ Energy: A Randomized, Blinded, Placebo-controlled Study of Cannabinoid Formulations and Their Effects on Energy Levels, Focus, Appetite and Other Health Outcomes

A randomized, blinded, placebo-controlled study of cannabinoid formulations and their effects on energy levels, focus, appetite and other health outcomes

Study Overview

Status

Completed

Conditions

Detailed Description

This is a randomized, blinded, placebo-controlled study conducted with up to 300 adult participants per study arm (3000 total), age 21 and older and residing in the United States.

Eligible participants will (1) endorse a desire for more energy (less fatigue and/or better concentration/focus during screening); (2) indicate a willingness to refrain from taking cannabinoids during the study period, and (3) indicate an interest in taking a plant derived cannabinoid product to help with their energy and/or focus.

Participants with known liver disease, heavy drinkers, and those who are pregnant, trying to become pregnant, or breastfeeding will be excluded. Those taking medications that warn against grapefruit consumption will be excluded. People with a calculated BMI of 18.5 or less will be excluded.

Self-reported data are collected electronically from eligible participants over 5 weeks. Participant reports of health indicators will be collected during baseline, throughout the active period of study product use, and in a final survey. All study assessments will be electronic; there are no in-person visits or assessments for this real-world evidence study.

Study Type

Interventional

Enrollment (Actual)

1427

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Del Mar, California, United States, 92014
        • Radicle Science, Inc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 105 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 21 years of age and older
  • Resides in the United States
  • Endorses: a desire for more energy (less fatigue) and/or a desire for better concentration (focus/attention)
  • Selects more energy and/or better concentration as a primary reason for taking a cannabinoid product
  • Expresses a willingness to refrain from taking any non-study cannabinoid product (i.e.

CBD, THC) for the duration of participant engagement

  • Expresses a willingness to take a study product and not knowing the product identity until the end of the study

Exclusion Criteria:

Pregnant, trying to become pregnant, or breastfeeding Reports a diagnosis of liver disease Reports being a heavy drinker (defined as drinking 3 or more alcoholic beverages per day) Unable to read and understand English Lack of reliable daily access to the internet Reports taking any medication that warns against grapefruit consumption Calculated BMI 18.5 or less

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Control 1
Energy Product Form 1 - control
Participants will use their Radicle Energy study product as directed for a period of 4 weeks.
Placebo Comparator: Control 2
Energy Product Form 2 - control
Participants will use their Radicle Energy study product as directed for a period of 4 weeks.
Experimental: Energy Product 1.1
Energy Product Form 1 - active product 1
Participants will use their Radicle Energy study product as directed for a period of 4 weeks.
Experimental: Energy Product 1.2
Energy Product Form 1 - active product 2
Participants will use their Radicle Energy study product as directed for a period of 4 weeks.
Experimental: Energy Product 2.1
Energy Product Form 2 - active 1
Participants will use their Radicle Energy study product as directed for a period of 4 weeks.
Experimental: Energy Product 2.2
Energy Product Form 2 - active 2
Participants will use their Radicle Energy study product as directed for a period of 4 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in energy
Time Frame: 4 weeks
Change in mean energy score as assessed by Patient Reported Outcome Measurement System (PROMIS) Fatigue 7a (scale 1-5; where lower score is less fatigue)
4 weeks
Change in focus
Time Frame: 4 weeks
Change in concentration (ability to focus) score as assessed by PROMIS™ Cognition 6a (scale 1-5; where lower score is worse focus (cognitive function))
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in energy (measure 2)
Time Frame: 4 weeks
Change in energy level score as assessed by a visual analog scale (VAS; Scoring from 0 to 10, with 0 being 'No energy' and 10 being 'More than enough energy')
4 weeks
Change in body weight
Time Frame: 4 weeks
Change in body weight as assessed by self-reported body weight in pounds
4 weeks
Change in appetite
Time Frame: 4 weeks
Change in appetite as assessed by a visual appetite scale (VAS; Scoring from 0 to 10, with 0 being 'No hunger' and 10 being 'Always hungry')
4 weeks
Change in overall quality of life (QOL)
Time Frame: 4 weeks
Change in QOL score as assessed by Kemp QOL (scale 1-7; with higher scores corresponding to higher quality of life)
4 weeks
Change in overall well-being
Time Frame: 4 weeks
Change in well-being score as assessed by World Health Organization 5 Well-being Index (WHO-5 Well-being Index; with higher scores corresponding to greater well-being)
4 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in pain
Time Frame: 4 weeks
Change in pain score as assessed by the Pain on average, Enjoyment of life, and General activity Score (PEG; scale 0-10 where 0 is no pain)
4 weeks
Change in Sleep quality
Time Frame: 4 weeks
Change in sleep quality (sleep disturbance) score as assessed by the PROMIS Sleep Disturbance 4A (scale 4 to 20; where higher scores correspond to higher levels of sleep disturbance)
4 weeks
Change in feelings of anxiety
Time Frame: 4 weeks
Change in anxiety score as assessed by the PROMIS Anxiety 4a (scale 4-20; where higher scores correspond to greater levels of anxiety)
4 weeks
Change in Stress
Time Frame: 4 weeks
Change in stress score as assessed by the PROMIS Stress 4a (scale 4-20; where higher scores correspond to greater levels of stress)
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Emily K Pauli, PharmD, Radicle Science, Inc

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 17, 2022

Primary Completion (Actual)

December 31, 2022

Study Completion (Actual)

May 24, 2023

Study Registration Dates

First Submitted

August 8, 2022

First Submitted That Met QC Criteria

August 12, 2022

First Posted (Actual)

August 16, 2022

Study Record Updates

Last Update Posted (Actual)

November 22, 2023

Last Update Submitted That Met QC Criteria

November 20, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • RADX-22D02

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data will not be shared with researchers outside of Radicle Collaborators on this study.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Energy

Clinical Trials on Energy Study Product Usage

Subscribe